Chiome Bioscience Inc.【JP:4583】Cash flow
Market cap
¥7.4B
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 102 | 113 | 11 | 7 | 5 | 4 | 3 | 1 | 1 | 1 | 4 |
| Cash from operations | -1,245 | -970 | -867 | -1,689 | -1,537 | -1,360 | -1,131 | -1,191 | -1,069 | -1,001 | -936 |
| Capital expenditures | -164 | -10 | -5 | - | - | - | - | - | - | - | -40 |
| Cash from investing | -1,780 | 1,989 | -137 | - | -26 | -4 | -35 | - | 0 | - | -55 |
| Proceeds from issuance of term debt, net | 100 | - | - | - | - | - | - | - | - | - | - |
| Repayments of term debt | - | -46 | -50 | -4 | - | - | - | - | - | - | - |
| Cash from financing | 124 | 1,434 | 479 | -10 | 1,341 | 1,944 | 271 | 1,127 | 667 | 1,738 | 133 |